Ting Wen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ting Wen has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Peiyuan Tang
Department of Orthopedics, Xiangya Hospital, Central South University , Xiangya Road, Kaifu District, Changsha, Hunan 410008
3 shared publications - Wenfeng Xiao
Department of Orthopedics, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China
3 shared publications - Yangbin Cao
Xiangya School of Medicine, Central South University, Changsha, China
3 shared publications - Yusheng Li
Department of Orthopaedics, Xiangya Hospital, Central South University, Changsha, China
3 shared publications - Djandan Tadum Arthur Vithran
Department of Orthopedics, Xiangya Hospital, Central South University , Changsha, Hunan
2 shared publications - Shuguang Liu
Department of Joint Surgery, Honghui Hospital, Xi’an Jiaotong University, Xi’an, China
2 shared publications
Latest Publications
- Open Access
- 4 August 2025
- Published by International Society of Global Health in Journal of Global Health
- Vol. 15, 04222
Beverage consumption on bone and joint disorders: an umbrella review
Bone and joint disorders significantly contribute to disability worldwide. While meta-analyses have explored the relationship of these diseases and beverage consumption, the results remain inconsistent. In this umbrella review, we synthesised existing evidence to clarify these associations. We conducted a systematic search in PubMed, Embase, Cochrane, and Web of Science up to January 2025. Two independent reviewers screened studies and extracted data based on predefined criteria. We included meta-analyses and systematic review studies. We used the Graphical Representation of Overlap for Overviews tool to manage overlapping studies and assessed methodological quality and evidence levels using AMSTAR 2 tool and the GRADE system. We narratively synthesised the findings and summarised them in tables. We included 20 meta-analyses. Tea consumption was associated with a reduced risk of osteoporosis (odds ratio (OR) = 0.71; 95% confidence interval (CI) = 0.60, 0.83; P < 0.0001; I2 = 13%), while coffee showed mixed results. Alcohol intake increased osteoporosis risk (OR = 2.95; 95% CI = 1.78, 4.9; P < 0.0001; I2 = 0%). Sugar-sweetened beverages raised gout risk (relative risk (RR) = 1.35; 95% CI = 1.18, 1.55, P < 0.05; I2 = 40.1%) and serum uric acid levels, while coffee lowered gout risk (RR = 0.43; 95% CI = 0.31, 0.59; P < 0.001; I2 = 0%). Coffee was associated with a higher risk of rheumatoid arthritis (RR = 1.3; 95% CI = 1.04, 1.62; P < 0.05; I2 = 0%), while tea showed no significant effect. Tea may benefit bone and joint health, while alcohol and sugar-sweetened beverages are associated with a higher incidence of bone and joint conditions, such as osteoporosis, rheumatoid arthritis, and gout. These findings emphasise the importance of dietary choices in preventing bone and joint disorders. PROSPERO (CRD42024551504).
- 4 August 2025
- Published by International Society of Global Health in Journal of Global Health
- Vol. 15, 04222
Open AccessBeverage consumption on bone and joint disorders: an umbrella review
Bone and joint disorders significantly contribute to disability worldwide. While meta-analyses have explored the relationship of these diseases and beverage consumption, the results remain inconsistent. In this umbrella review, we synthesised existing evidence to clarify these associations. We conducted a systematic search in PubMed, Embase, Cochrane, and Web of Science up to January 2025. Two independent reviewers screened studies and extracted data based on predefined criteria. We included meta-analyses and systematic review studies. We used the Graphical Representation of Overlap for Overviews tool to manage overlapping studies and assessed methodological quality and evidence levels using AMSTAR 2 tool and the GRADE system. We narratively synthesised the findings and summarised them in tables. We included 20 meta-analyses. Tea consumption was associated with a reduced risk of osteoporosis (odds ratio (OR) = 0.71; 95% confidence interval (CI) = 0.60, 0.83; P < 0.0001; I2 = 13%), while coffee showed mixed results. Alcohol intake increased osteoporosis risk (OR = 2.95; 95% CI = 1.78, 4.9; P < 0.0001; I2 = 0%). Sugar-sweetened beverages raised gout risk (relative risk (RR) = 1.35; 95% CI = 1.18, 1.55, P < 0.05; I2 = 40.1%) and serum uric acid levels, while coffee lowered gout risk (RR = 0.43; 95% CI = 0.31, 0.59; P < 0.001; I2 = 0%). Coffee was associated with a higher risk of rheumatoid arthritis (RR = 1.3; 95% CI = 1.04, 1.62; P < 0.05; I2 = 0%), while tea showed no significant effect. Tea may benefit bone and joint health, while alcohol and sugar-sweetened beverages are associated with a higher incidence of bone and joint conditions, such as osteoporosis, rheumatoid arthritis, and gout. These findings emphasise the importance of dietary choices in preventing bone and joint disorders. PROSPERO (CRD42024551504).
- Open Access
- 25 April 2025
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 27, e64576
The Efficacy of Virtual Reality on the Rehabilitation of Musculoskeletal Diseases: Umbrella Review
Background: Musculoskeletal disorders cause pain, disability, and financial burdens, with rising prevalence. Virtual reality (VR) offers immersive, digital rehabilitation potential, improving motor functions and pain management. Objective: To evaluate the impact of VR on the rehabilitation of musculoskeletal disorders and to assess the consistency of evidence provided by existing systematic reviews and meta-analyses, this study focuses on musculoskeletal disorders, which encompass conditions affecting the locomotor system, such as arthritis, joint deformities, and injuries. VR therapy leverages immersive digital environments to enhance rehabilitation through digital exercises and simulations. Methods: The PubMed or MEDLINE, Embase, and Cochrane Library databases were systematically searched for relevant papers published up to April 2024. Literature screening, quality assessment, and data extraction were conducted according to predefined inclusion and exclusion criteria. The methodological quality of the included meta-analyses was evaluated using the Measurement Tool to Assess Systematic Reviews 2. The Grading of Recommendations Assessment, Development, and Evaluation system was used to classify the evidence level for each outcome as high, moderate, low, or very low. Additionally, the evidence was categorized into 5 levels based on classification criteria: I (convincing), II (highly suggestive), III (suggestive), IV (weak), and nonsignificant. Results: This umbrella review synthesized data from 14 meta-analyses published between 2019 and 2024, involving a total of 13,184 patients. In total, 7 meta-analyses received high Measurement Tool to Assess Systematic Reviews 2 ratings, 7 were rated moderate, and the remainder were rated low. VR demonstrated promising results in musculoskeletal rehabilitation, significantly reducing knee pain (mean difference [MD] –1.38, 95% CI –2.32 to –0.44; P=.004; I2=94%) and improving balance. For patients with fibromyalgia syndrome, VR effectively reduced pain (standardized mean difference [SMD] –0.45, 95% CI –0.70 to –0.20; P<.001), fatigue (SMD –0.58, 95% CI –1.01 to –0.14; P=.01), anxiety (SMD –0.50, 95% CI –0.908 to –0.029; P=.04), and depression (SMD –0.62, 95% CI –0.76 to –0.15; P=.003) while also enhancing quality of life. In individuals with back pain, VR alleviated pain-related fears (MD –5.46, 95% CI –9.40 to –1.52; P=.007; I2=90%) and reduced pain intensity (MD –1.43, 95% CI –1.86 to –1.00; P<.001; I2=95%). After arthroplasty, VR improved knee functionality (MD 8.30, 95% CI 6.92-9.67; P<.001; I2=24%) and decreased anxiety (MD –3.95, 95% CI –7.76 to –0.13; P=.04; I2=0%). Conclusions: VR demonstrates significant potential in the rehabilitation of various musculoskeletal conditions. It effectively alleviates pain, enhances psychological well-being, and facilitates the recovery of motor function in patients. Trial Registration: PROSPERO CRD42024538469; https://www.crd.york.ac.uk/PROSPERO/view/CRD42024538469
- 25 April 2025
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 27, e64576
Open AccessThe Efficacy of Virtual Reality on the Rehabilitation of Musculoskeletal Diseases: Umbrella Review
Background: Musculoskeletal disorders cause pain, disability, and financial burdens, with rising prevalence. Virtual reality (VR) offers immersive, digital rehabilitation potential, improving motor functions and pain management. Objective: To evaluate the impact of VR on the rehabilitation of musculoskeletal disorders and to assess the consistency of evidence provided by existing systematic reviews and meta-analyses, this study focuses on musculoskeletal disorders, which encompass conditions affecting the locomotor system, such as arthritis, joint deformities, and injuries. VR therapy leverages immersive digital environments to enhance rehabilitation through digital exercises and simulations. Methods: The PubMed or MEDLINE, Embase, and Cochrane Library databases were systematically searched for relevant papers published up to April 2024. Literature screening, quality assessment, and data extraction were conducted according to predefined inclusion and exclusion criteria. The methodological quality of the included meta-analyses was evaluated using the Measurement Tool to Assess Systematic Reviews 2. The Grading of Recommendations Assessment, Development, and Evaluation system was used to classify the evidence level for each outcome as high, moderate, low, or very low. Additionally, the evidence was categorized into 5 levels based on classification criteria: I (convincing), II (highly suggestive), III (suggestive), IV (weak), and nonsignificant. Results: This umbrella review synthesized data from 14 meta-analyses published between 2019 and 2024, involving a total of 13,184 patients. In total, 7 meta-analyses received high Measurement Tool to Assess Systematic Reviews 2 ratings, 7 were rated moderate, and the remainder were rated low. VR demonstrated promising results in musculoskeletal rehabilitation, significantly reducing knee pain (mean difference [MD] –1.38, 95% CI –2.32 to –0.44; P=.004; I2=94%) and improving balance. For patients with fibromyalgia syndrome, VR effectively reduced pain (standardized mean difference [SMD] –0.45, 95% CI –0.70 to –0.20; P<.001), fatigue (SMD –0.58, 95% CI –1.01 to –0.14; P=.01), anxiety (SMD –0.50, 95% CI –0.908 to –0.029; P=.04), and depression (SMD –0.62, 95% CI –0.76 to –0.15; P=.003) while also enhancing quality of life. In individuals with back pain, VR alleviated pain-related fears (MD –5.46, 95% CI –9.40 to –1.52; P=.007; I2=90%) and reduced pain intensity (MD –1.43, 95% CI –1.86 to –1.00; P<.001; I2=95%). After arthroplasty, VR improved knee functionality (MD 8.30, 95% CI 6.92-9.67; P<.001; I2=24%) and decreased anxiety (MD –3.95, 95% CI –7.76 to –0.13; P=.04; I2=0%). Conclusions: VR demonstrates significant potential in the rehabilitation of various musculoskeletal conditions. It effectively alleviates pain, enhances psychological well-being, and facilitates the recovery of motor function in patients. Trial Registration: PROSPERO CRD42024538469; https://www.crd.york.ac.uk/PROSPERO/view/CRD42024538469
- Open Access
- 21 July 2024
- Published by JMIR Publications Inc. in JMIR Preprints
The Efficacy of Virtual Reality on the Rehabilitation of Musculoskeletal Diseases: Umbrella Review (Preprint)
BACKGROUND Musculoskeletal disorders cause pain, disability, and financial burdens, with rising prevalence. Virtual reality (VR) offers immersive, digital rehabilitation potential, improving motor functions and pain management. OBJECTIVE To evaluate the impact of VR on the rehabilitation of musculoskeletal disorders and to assess the consistency of evidence provided by existing systematic reviews and meta-analyses, this study focuses on musculoskeletal disorders, which encompass conditions affecting the locomotor system, such as arthritis, joint deformities, and injuries. VR therapy leverages immersive digital environments to enhance rehabilitation through digital exercises and simulations. METHODS The PubMed or MEDLINE, Embase, and Cochrane Library databases were systematically searched for relevant papers published up to April 2024. Literature screening, quality assessment, and data extraction were conducted according to predefined inclusion and exclusion criteria. The methodological quality of the included meta-analyses was evaluated using the Measurement Tool to Assess Systematic Reviews 2. The Grading of Recommendations Assessment, Development, and Evaluation system was used to classify the evidence level for each outcome as high, moderate, low, or very low. Additionally, the evidence was categorized into 5 levels based on classification criteria: I (convincing), II (highly suggestive), III (suggestive), IV (weak), and nonsignificant. RESULTS This umbrella review synthesized data from 14 meta-analyses published between 2019 and 2024, involving a total of 13,184 patients. In total, 7 meta-analyses received high Measurement Tool to Assess Systematic Reviews 2 ratings, 7 were rated moderate, and the remainder were rated low. VR demonstrated promising results in musculoskeletal rehabilitation, significantly reducing knee pain (mean difference [MD] –1.38, 95% CI –2.32 to –0.44; P=.004; I2=94%) and improving balance. For patients with fibromyalgia syndrome, VR effectively reduced pain (standardized mean difference [SMD] –0.45, 95% CI –0.70 to –0.20; P<.001), fatigue (SMD –0.58, 95% CI –1.01 to –0.14; P=.01), anxiety (SMD –0.50, 95% CI –0.908 to –0.029; P=.04), and depression (SMD –0.62, 95% CI –0.76 to –0.15; P=.003) while also enhancing quality of life. In individuals with back pain, VR alleviated pain-related fears (MD –5.46, 95% CI –9.40 to –1.52; P=.007; I2=90%) and reduced pain intensity (MD –1.43, 95% CI –1.86 to –1.00; P<.001; I2=95%). After arthroplasty, VR improved knee functionality (MD 8.30, 95% CI 6.92-9.67; P<.001; I2=24%) and decreased anxiety (MD –3.95, 95% CI –7.76 to –0.13; P=.04; I2=0%). CONCLUSIONS VR demonstrates significant potential in the rehabilitation of various musculoskeletal conditions. It effectively alleviates pain, enhances psychological well-being, and facilitates the recovery of motor function in patients. CLINICALTRIAL PROSPERO CRD42024538469; https://www.crd.york.ac.uk/PROSPERO/view/CRD42024538469
- 21 July 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessThe Efficacy of Virtual Reality on the Rehabilitation of Musculoskeletal Diseases: Umbrella Review (Preprint)
BACKGROUND Musculoskeletal disorders cause pain, disability, and financial burdens, with rising prevalence. Virtual reality (VR) offers immersive, digital rehabilitation potential, improving motor functions and pain management. OBJECTIVE To evaluate the impact of VR on the rehabilitation of musculoskeletal disorders and to assess the consistency of evidence provided by existing systematic reviews and meta-analyses, this study focuses on musculoskeletal disorders, which encompass conditions affecting the locomotor system, such as arthritis, joint deformities, and injuries. VR therapy leverages immersive digital environments to enhance rehabilitation through digital exercises and simulations. METHODS The PubMed or MEDLINE, Embase, and Cochrane Library databases were systematically searched for relevant papers published up to April 2024. Literature screening, quality assessment, and data extraction were conducted according to predefined inclusion and exclusion criteria. The methodological quality of the included meta-analyses was evaluated using the Measurement Tool to Assess Systematic Reviews 2. The Grading of Recommendations Assessment, Development, and Evaluation system was used to classify the evidence level for each outcome as high, moderate, low, or very low. Additionally, the evidence was categorized into 5 levels based on classification criteria: I (convincing), II (highly suggestive), III (suggestive), IV (weak), and nonsignificant. RESULTS This umbrella review synthesized data from 14 meta-analyses published between 2019 and 2024, involving a total of 13,184 patients. In total, 7 meta-analyses received high Measurement Tool to Assess Systematic Reviews 2 ratings, 7 were rated moderate, and the remainder were rated low. VR demonstrated promising results in musculoskeletal rehabilitation, significantly reducing knee pain (mean difference [MD] –1.38, 95% CI –2.32 to –0.44; P=.004; I2=94%) and improving balance. For patients with fibromyalgia syndrome, VR effectively reduced pain (standardized mean difference [SMD] –0.45, 95% CI –0.70 to –0.20; P<.001), fatigue (SMD –0.58, 95% CI –1.01 to –0.14; P=.01), anxiety (SMD –0.50, 95% CI –0.908 to –0.029; P=.04), and depression (SMD –0.62, 95% CI –0.76 to –0.15; P=.003) while also enhancing quality of life. In individuals with back pain, VR alleviated pain-related fears (MD –5.46, 95% CI –9.40 to –1.52; P=.007; I2=90%) and reduced pain intensity (MD –1.43, 95% CI –1.86 to –1.00; P<.001; I2=95%). After arthroplasty, VR improved knee functionality (MD 8.30, 95% CI 6.92-9.67; P<.001; I2=24%) and decreased anxiety (MD –3.95, 95% CI –7.76 to –0.13; P=.04; I2=0%). CONCLUSIONS VR demonstrates significant potential in the rehabilitation of various musculoskeletal conditions. It effectively alleviates pain, enhances psychological well-being, and facilitates the recovery of motor function in patients. CLINICALTRIAL PROSPERO CRD42024538469; https://www.crd.york.ac.uk/PROSPERO/view/CRD42024538469